about
Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discoveryAnalysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffoldsUpdates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database.Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network.Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancers.Transcriptional landscapes of emerging autoimmunity: transient aberrations in the targeted tissue's extracellular milieu precede immune responses in Sjögren's syndrome.Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective.Old friends in new guise: repositioning of known drugs with structural bioinformatics.Literature mining, ontologies and information visualization for drug repurposing.Compound annotation with real time cellular activity profiles to improve drug discovery.Text Mining for Drugs and Chemical Compounds: Methods, Tools and Applications.Progress in the Visualization and Mining of Chemical and Target Spaces.MediSyn: uncertainty-aware visualization of multiple biomedical datasets to support drug treatment selectionThe Internet as Scientific Knowledge Base: Navigating the Chem-Bio Space.Differential gene expression in disease: a comparison between high-throughput studies and the literature.Translatability score revisited: differentiation for distinct disease areas.From Virtual Screening to Bioactive Compounds by Visualizing and Clustering of Chemical Space
P2860
Q27144251-40CA5CB3-0797-498D-BAB2-4062AEDC8338Q29042705-29E51B6D-01E0-470C-8428-602AAC95F741Q31009476-462533F0-6DB3-448E-8ABB-A3A58A8C5B57Q33858671-2ECDDA6F-35BF-4DA1-93B3-1325A574431DQ34271192-8CC2F38F-FDF1-4015-8E52-DE66E8BF91E7Q36107446-81854D8C-908B-467C-A2C0-AEC55F28D2A0Q37689748-005959DA-323D-4ADC-AE8D-5215648AA403Q37780606-20251ACE-A54F-4467-A7A7-2196C152F068Q37858324-4F0B4FEF-1F7E-45BB-AA44-78FD2725B414Q37895399-3647568F-B9E4-4247-A447-04E570A1D0E1Q38452129-9AE94917-11AB-452D-B519-4913D65D5A85Q38911008-7CA97D59-84DA-4C5F-9DB9-ADFD3DACB04DQ38915513-BA179579-DFE5-430A-B626-45F214F52F7BQ41695691-39F2A3C5-09F0-499E-84A5-F9ED23EF414DQ42090472-23DDE108-48B7-4538-9802-E06B412ECD96Q42375274-AD3A064C-42A8-4334-B6CB-FF6AB7E90214Q47101734-7D3E19AD-D7B0-48AB-8D12-0A3717569EA5Q57002994-09499EB1-0FB2-4321-840A-D691AE033DC5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Visualizing the drug target landscape.
@en
type
label
Visualizing the drug target landscape.
@en
prefLabel
Visualizing the drug target landscape.
@en
P2093
P1433
P1476
Visualizing the drug target landscape.
@en
P2093
Cory Brouwer
Dmitri Bichko
Jason Marshall
Sid Martin
Stephen J Campbell
P356
10.1016/J.DRUDIS.2009.09.011
P577
2009-10-17T00:00:00Z